Our study revealed the close relationships between PDIA5 and immune checkpoint genes in multiple human cancers, strengthening the hypothesis that PDIA5 might enhance immunotherapy responses by synergizing with known immune checkpoint inhibitors in cancers. Here, PDIA5 is linked to cancer.